Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 6964

Sort by

Sort Order Select

Journal Articles

Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT

Duneia McManus, Sabrina N. Copsel, Brent J. Pfeiffer, Dietlinde Wolf, Henry Barreras, Symon Ma, Ali Khodor, Seitaro Komai, Marina Burgos da Silva, Hajar Hazime, Miguel Gallardo, Sarah Grace Lime, Marcel R. M. van den Brink, Jung-Hyun Park, Maria T. Abreu, Geoffrey R. Hill, Victor L. Perez, Robert B. Levy

Blood (2025) 146 (22): 2710–2727.

https://doi.org/10.1182/blood.2025028418

Published: 2025

Includes: Supplemental data

Journal Articles

Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging

Blood (2025) 146 (22): 2681–2695.

https://doi.org/10.1182/blood.2024027692

Published: 2025

Includes: Supplemental data

Journal Articles

Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling

Sina A. Beer, David A. Cairns, Charlotte Pawlyn, Amy Holroyd, Elsa Ferris, Gordon Cook, Mark Drayson, Kevin Boyd, Paula Proszek, Faith E. Davies, Ruth de Tute, Matthew Jenner, Gareth J. Morgan, Roger Owen, Michael Hubank, Richard Houlston, Graham Jackson, Martin F. Kaiser

Blood (2025) 146 (22): 2670–2680.

https://doi.org/10.1182/blood.2025029987

Published: 2025

Includes: Supplemental data

Journal Articles

A prime editing strategy to rewrite the γ-globin promoters and reactivate fetal hemoglobin for sickle cell disease

Anne Chalumeau, Maria Bou Dames, Letizia Fontana, Simone Amistadi, Panagiotis Antoniou, Priyanka Loganathan, Margaux Mombled, Guillaume Corre, Martin Peterka, Mario Amendola, Carine Giovannangeli, Marcello Maresca, Annarita Miccio, Mégane Brusson

Blood (2025) 146 (22): 2641–2655.

https://doi.org/10.1182/blood.2024028166

Published: 2025

Includes: Supplemental data

Journal Articles

Fixed-duration epcoritamab plus R 2 drives favorable outcomes in relapsed or refractory follicular lymphoma

Blood (2025) 146 (22): 2629–2640.

https://doi.org/10.1182/blood.2025029909

Published: 2025

Includes: Supplemental data

Journal Articles

Old but gold: ILC-induced T-cell senescence prevents GVHD

Sophia Chen

Blood (2025) 146 (22): 2620–2621.

https://doi.org/10.1182/blood.2025030805

Published: 2025

Journal Articles

MASTering KIT : enhanced sensitivity for refined diagnosis

Yannick Chantran, Michel Arock

Blood (2025) 146 (22): 2624–2626.

https://doi.org/10.1182/blood.2025030940

Published: 2025

Journal Articles

Death receptor 3 gives life to Tregs in GVHD

Haroon Shaikh

Blood (2025) 146 (22): 2626–2627.

https://doi.org/10.1182/blood.2025030671

Published: 2025

Journal Articles

Better together: epcoritamab boosts R2 in FL

Umberto Vitolo, Francesca Bonello

Blood (2025) 146 (22): 2617–2619.

https://doi.org/10.1182/blood.2025031236

Published: 2025

Journal Articles

Above the cut: HbF induction by multiplex prime editing

Carsten W. Lederer

Blood (2025) 146 (22): 2619–2620.

https://doi.org/10.1182/blood.2025031005

Published: 2025

Journal Articles

Explain the unexplained

Jill Corre

Blood (2025) 146 (22): 2622–2623.

https://doi.org/10.1182/blood.2025030944

Published: 2025

Journal Articles

Proteomics: the key to understanding AML hematopoietic aging

Sara J. C. Gosline

Blood (2025) 146 (22): 2623–2624.

https://doi.org/10.1182/blood.2025030883

Published: 2025

Journal Articles

Yeung DT, Shanmuganathan N, Reynolds J, et al; Australasian Leukaemia and Lymphoma Group. Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study. Blood. 2024;144(19):1993-2001.

Blood (2025) 146 (22): 2729.

https://doi.org/10.1182/blood.2025031951

Published: 2025

Journal Articles

FLI1 -related thrombocytopenia: piecing together the story

Richard C. Godby, Dong Chen

Blood (2025) 146 (22): 2728.

https://doi.org/10.1182/blood.2025030799

Published: 2025

Journal Articles

TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma

Blood (2025) 146 (21): 2544–2560.

https://doi.org/10.1182/blood.2024026919

Published: 2025

Includes: Supplemental data

Journal Articles

A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma

Peng-Peng Xu, Yue Zhu, Zi-Yang Shi, Li Wang, Shu Cheng, Ying Qian, Yan Zhao, Yang He, Hong-Mei Yi, Bin-shen Ou-yang, Xu-Feng Jiang, Biao Li, Qi Song, Rong-Ji Mu, Wei-Li Zhao

Blood (2025) 146 (21): 2561–2573.

https://doi.org/10.1182/blood.2025028649

Published: 2025

Includes: Supplemental data

Journal Articles

Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia

Cristiana O’Brien, Nirvana Nursimulu, Anit Tyagi, Rachel Culp-Hill, Andrea Arruda, Tracy Murphy, Mark D. Minden, Andrew Kent, Brett Stevens, Daniel A. Pollyea, Kristin Hope, Sushant Kumar, Julie A. Reisz, Angelo D'Alessandro, Courtney L. Jones

Blood (2025) 146 (21): 2589–2596.

https://doi.org/10.1182/blood.2025029132

Published: 2025

Includes: Supplemental data

Journal Articles

Isatuximab for relapsed and/or refractory AL amyloidosis: results of a prospective phase 2 trial (SWOG S1702)

Terri L. Parker, Adam Rosenthal, Vaishali Sanchorawala, Heather J. Landau, Erica L. Campagnaro, Prashant Kapoor, Natalia Neparidze, Saulius Girnius, Patrick Hagen, Emma C. Scott, Antje Hoering, Brian G. M. Durie, Robert Z. Orlowski

Blood (2025) 146 (21): 2507–2516.

https://doi.org/10.1182/blood.2024027962

Published: 2025

Journal Articles

Big cells, bigger BTK resistance in mantle cell lymphoma

Justin Taylor

Blood (2025) 146 (21): 2500–2501.

https://doi.org/10.1182/blood.2025029937

Published: 2025

Journal Articles

Neri P, Ren L, Azab AK, et al. Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion. Blood. 2011;117(23):6202-6213.

Blood (2025) 146 (21): 2613.

https://doi.org/10.1182/blood.2025031937

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT

Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging

Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling

A prime editing strategy to rewrite the γ-globin promoters and reactivate fetal hemoglobin for sickle cell disease

Fixed-duration epcoritamab plus R 2 drives favorable outcomes in relapsed or refractory follicular lymphoma

Old but gold: ILC-induced T-cell senescence prevents GVHD

MASTering KIT : enhanced sensitivity for refined diagnosis

Death receptor 3 gives life to Tregs in GVHD

Better together: epcoritamab boosts R2 in FL

Above the cut: HbF induction by multiplex prime editing

Explain the unexplained

Proteomics: the key to understanding AML hematopoietic aging

Yeung DT, Shanmuganathan N, Reynolds J, et al; Australasian Leukaemia and Lymphoma Group. Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study. Blood. 2024;144(19):1993-2001.

FLI1 -related thrombocytopenia: piecing together the story

TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma

A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma

Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia

Isatuximab for relapsed and/or refractory AL amyloidosis: results of a prospective phase 2 trial (SWOG S1702)

Big cells, bigger BTK resistance in mantle cell lymphoma

Neri P, Ren L, Azab AK, et al. Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion. Blood. 2011;117(23):6202-6213.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only